MYADMIA

View On IC.GC.CA

ADVERTISED

on 4 Dec 2024

Last Applicant/ Owned by

Takeda Pharmaceuticals International AG

Thurgauerstrasse 130CH-8152 Glattpark-Opfikon

Serial Number

2238630 filed on 21^st Dec 2022

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

MYADMIA

Trademark usage description

préparations pharmaceutiques, à savoir thérapie enzymatique substitutive pour le traitement des troubles sanguins thrombotiques.

Classification Information

2238630

Trademark

Action Taken	Status
Submitted for opposition 22 on 21^st Feb 2024	Search Recorded
Submitted for opposition 20 on 21^st Feb 2024	Examiner's First Report
Submitted for opposition 223 on 21^st Feb 2024	Total Provisional Refusal
Submitted for opposition 48 on 15^th Jan 2024	Agent Changed
Submitted for opposition 256 on 11^th Dec 2023	Notification of Possible Opposition Sent
Submitted for opposition 257 on 9^th Feb 2023	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 8^th Feb 2023	Formalized
Submitted for opposition 1 on 8^th Feb 2023	Created
Submitted for opposition 228 on 21^st Dec 2022	International Registration
Submitted for opposition 30 on 21^st Dec 2022	Filed